Trials / Unknown
UnknownNCT01664507
The Effect and Safety of Low Dose Nebulized Epinephrine in Croup
The Effect and Safety of Low Dose Nebulized Epinephrine in the Treatment of Croup
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 6 Months – 5 Years
- Healthy volunteers
- Accepted
Summary
Croup is common illness presenting emergency department with dyspnea. The main treatment for croup is nebulized L-epinephrine and steroid. The study for the dose of nebulized L-epinephrine is restricted that the study of comparision between racemic epinephrine and L-epinephrine. The investigators conducted this study to compare the effectiveness of low dose L-epinephrine with conventional dose L-epinephrine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | conventional dose epinephrine | conventional dose epinephrine : 0.5mg/kg + 0.9% normal saline |
| DRUG | low dose epinephrine | low dose epineprhine : 0.1mg/kg + 0.9% normal saline |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
- First posted
- 2012-08-14
- Last updated
- 2018-01-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01664507. Inclusion in this directory is not an endorsement.